In neuroblastoma, where PLK4 is found to be upregulated, its expression is negatively correlated with poor clinical and survival parameters, while PLK4 downregulation suppresses neuroblastoma cells migration and invasion by inhibiting EMT via the PI3 K/Akt signaling [61]. This evidence concerns the gene AKT1 and neuroblastoma.